Jennifer L Robinson

Author PubWeight™ 79.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol 2003 3.05
2 Long QT syndrome in adults. J Am Coll Cardiol 2007 2.93
3 Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biol Psychiatry 2008 2.91
4 Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation 2007 2.88
5 Genotype-phenotype aspects of type 2 long QT syndrome. J Am Coll Cardiol 2009 2.65
6 Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation 2004 2.63
7 Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation 2008 2.40
8 Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome. J Cardiovasc Electrophysiol 2008 2.39
9 ALE Meta-Analysis Workflows Via the Brainmap Database: Progress Towards A Probabilistic Functional Brain Atlas. Front Neuroinform 2009 2.29
10 Modulating effects of age and gender on the clinical course of long QT syndrome by genotype. J Am Coll Cardiol 2003 2.22
11 Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 2002 2.20
12 Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals. J Am Coll Cardiol 2011 2.15
13 Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. JAMA 2006 2.12
14 Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management. J Cardiovasc Electrophysiol 2010 1.99
15 Mutations in cytoplasmic loops of the KCNQ1 channel and the risk of life-threatening events: implications for mutation-specific response to β-blocker therapy in type 1 long-QT syndrome. Circulation 2012 1.89
16 Clinical course and risk stratification of patients affected with the Jervell and Lange-Nielsen syndrome. J Cardiovasc Electrophysiol 2006 1.88
17 Comparison of the disparity between Talairach and MNI coordinates in functional neuroimaging data: validation of the Lancaster transform. Neuroimage 2010 1.82
18 Clinical implications for patients with long QT syndrome who experience a cardiac event during infancy. J Am Coll Cardiol 2009 1.81
19 Long-QT syndrome after age 40. Circulation 2008 1.73
20 Long QT syndrome and pregnancy. J Am Coll Cardiol 2007 1.71
21 Risk of death in the long QT syndrome when a sibling has died. Heart Rhythm 2008 1.64
22 Risk factors for recurrent syncope and subsequent fatal or near-fatal events in children and adolescents with long QT syndrome. J Am Coll Cardiol 2011 1.59
23 Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome. Heart Rhythm 2011 1.54
24 Corrected QT variability in serial electrocardiograms in long QT syndrome: the importance of the maximum corrected QT for risk stratification. J Am Coll Cardiol 2006 1.48
25 The BrainMap strategy for standardization, sharing, and meta-analysis of neuroimaging data. BMC Res Notes 2011 1.47
26 Combined assessment of sex- and mutation-specific information for risk stratification in type 1 long QT syndrome. Heart Rhythm 2012 1.47
27 Prognostic implications of mutation-specific QTc standard deviation in congenital long QT syndrome. Heart Rhythm 2013 1.46
28 Risk of recurrent cardiac events after onset of menopause in women with congenital long-QT syndrome types 1 and 2. Circulation 2011 1.41
29 Risk of syncope in family members who are genotype-negative for a family-associated long-QT syndrome mutation. Circ Cardiovasc Genet 2011 1.40
30 Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial. Ann Noninvasive Electrocardiol 2005 1.31
31 Differential activation of the anterior cingulate cortex and caudate nucleus during a gambling simulation in persons with a family history of alcoholism: studies from the Oklahoma Family Health Patterns Project. Drug Alcohol Depend 2008 1.14
32 Risk of fatal arrhythmic events in long QT syndrome patients after syncope. J Am Coll Cardiol 2010 1.06
33 Thalamic medial dorsal nucleus atrophy in medial temporal lobe epilepsy: A VBM meta-analysis. Neuroimage Clin 2012 1.03
34 Up- and down-regulating facial disgust: affective, vagal, sympathetic, and respiratory consequences. Biol Psychol 2005 1.03
35 Long QT syndrome in patients over 40 years of age: increased risk for LQTS-related cardiac events in patients with coronary disease. Ann Noninvasive Electrocardiol 2008 0.98
36 Acute effects of hydrocortisone on the human brain: an fMRI study. Psychoneuroendocrinology 2010 0.96
37 Trigger-specific risk factors and response to therapy in long QT syndrome type 2. Heart Rhythm 2010 0.94
38 Risk of cardiac events in patients with asthma and long-QT syndrome treated with beta(2) agonists. Am J Cardiol 2008 0.93
39 Resting RSA is associated with natural and self-regulated responses to negative emotional stimuli. Brain Cogn 2004 0.93
40 Trigger-specific ion-channel mechanisms, risk factors, and response to therapy in type 1 long QT syndrome. Heart Rhythm 2011 0.92
41 Risk of life-threatening cardiac events among patients with long QT syndrome and multiple mutations. Heart Rhythm 2012 0.91
42 Use of mutant-specific ion channel characteristics for risk stratification of long QT syndrome patients. Sci Transl Med 2011 0.90
43 A social cognitive approach to emotional intensity judgment deficits in schizophrenia. Schizophr Res 2007 0.87
44 Mutations in conserved amino acids in the KCNQ1 channel and risk of cardiac events in type-1 long-QT syndrome. J Cardiovasc Electrophysiol 2009 0.85
45 Fronto-temporal dysregulation in asymptomatic bipolar I patients: a paired associate functional MRI study. Hum Brain Mapp 2010 0.85
46 Long QT syndrome in African-Americans. Ann Noninvasive Electrocardiol 2010 0.84
47 Mutation-specific risk in two genetic forms of type 3 long QT syndrome. Am J Cardiol 2010 0.80
48 Primacy and recency effects found using affective word lists. Cogn Behav Neurol 2004 0.79
49 Behavioral inhibition system (BIS) strength and trait dominance are associated with affective response and perspective taking when viewing dyadic interactions. Int J Neurosci 2005 0.78
50 Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome. Am Heart J 2007 0.78
51 Genotype-specific QT correction for heart rate and the risk of life-threatening cardiac events in adolescents with congenital long-QT syndrome. Heart Rhythm 2011 0.78
52 Phenotypic variability in Caucasian and Japanese patients with matched LQT1 mutations. Ann Noninvasive Electrocardiol 2008 0.77
53 Characterization of a resorbable poly(ester urethane) with biodegradable hard segments. J Biomater Sci Polym Ed 2014 0.76
54 Influence of diabetes mellitus on outcome in patients over 40 years of age with the long QT syndrome. Am J Cardiol 2009 0.75